Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Total Liabilities ₹416 Cr₹407 Cr₹378 Cr₹308 Cr₹184 Cr

What is the latest Total Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹416 Cr based on Mar2025 Consolidated results.
Year Total Liabilities
Mar2025₹416 Cr
Mar2024₹407 Cr
Mar2023₹378 Cr
Mar2022₹308 Cr
Mar2017₹184 Cr

How is Total Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Liabilities % Change
Mar2025 ₹416 Cr
2.18
Mar2024 ₹407 Cr
7.69
Mar2023 ₹378 Cr
22.58
Mar2022 ₹308 Cr
67.59
Mar2017 ₹184 Cr -

Compare Total Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,347.0 Cr 1.5% 5% -34.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,036.0 Cr 0.8% -4.2% 7% Stock Analytics
DIVIS LABORATORIES ₹178,218.0 Cr 1.1% -0.7% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹151,099.0 Cr 0% 1.3% 40.1% Stock Analytics
CIPLA ₹110,897.0 Cr -0.3% -4.1% -8.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,591.0 Cr 0.4% -4.5% -5.2% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

1.5%

5%

-34.3%

SENSEX

3.9%

1.9%

-6.8%


You may also like the below Video Courses